BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 1816067)

  • 1. Bone alkaline phosphatase in Paget's disease.
    Deftos LJ; Wolfert RL; Hill CS
    Horm Metab Res; 1991 Nov; 23(11):559-61. PubMed ID: 1816067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum osteocalcin concentrations in Paget's disease of bone.
    Wilkinson MR; Wagstaffe C; Delbridge L; Wiseman J; Posen S
    Arch Intern Med; 1986 Feb; 146(2):268-71. PubMed ID: 3484940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discriminative value of biochemical markers of bone turnover in assessing the activity of Paget's disease.
    Alvarez L; Guañabens N; Peris P; Monegal A; Bedini JL; Deulofeu R; Martinez de Osaba MJ; Muñoz-Gomez J; Rivera-Fillat F; Ballesta AM
    J Bone Miner Res; 1995 Mar; 10(3):458-65. PubMed ID: 7785468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term biochemical response after bisphosphonate therapy in Paget's disease of bone. Proposed intervals for monitoring treatment.
    Alvarez L; Peris P; Guañabens N; Vidal S; Quintó L; Monegal A; Pons F; Ballesta AM; Muñoz-Gómez J
    Rheumatology (Oxford); 2004 Jul; 43(7):869-74. PubMed ID: 15054158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of serum osteocalcin with total and bone specific alkaline phosphatase and urinary hydroxyproline:creatinine ratio in patients with Paget's disease of bone.
    Kaddam IM; Iqbal SJ; Holland S; Wong M; Manning D
    Ann Clin Biochem; 1994 Jul; 31 ( Pt 4)():327-30. PubMed ID: 7979096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New biochemical marker for bone metabolism. Measurement by radioimmunoassay of bone GLA protein in the plasma of normal subjects and patients with bone disease.
    Price PA; Parthemore JG; Deftos LJ
    J Clin Invest; 1980 Nov; 66(5):878-83. PubMed ID: 6968755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimation of bone turnover evaluated by 47Ca-kinetics. Efficiency of serum bone gamma-carboxyglutamic acid-containing protein, serum alkaline phosphatase, and urinary hydroxyproline excretion.
    Charles P; Poser JW; Mosekilde L; Jensen FT
    J Clin Invest; 1985 Dec; 76(6):2254-8. PubMed ID: 3878367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paget's disease of bone in New Zealand: continued decline in disease severity.
    Cundy HR; Gamble G; Wattie D; Rutland M; Cundy T
    Calcif Tissue Int; 2004 Nov; 75(5):358-64. PubMed ID: 15455187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum cathepsin K concentrations reflect osteoclastic activity in women with postmenopausal osteoporosis and patients with Paget's disease.
    Meier C; Meinhardt U; Greenfield JR; De Winter J; Nguyen TV; Dunstan CR; Seibel MJ
    Clin Lab; 2006; 52(1-2):1-10. PubMed ID: 16506358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of urinary excretion of nonisomerized and beta-isomerized forms of type I collagen breakdown products to monitor the effects of the bisphosphonate zoledronate in Paget's disease.
    Garnero P; Gineyts E; Schaffer AV; Seaman J; Delmas PD
    Arthritis Rheum; 1998 Feb; 41(2):354-60. PubMed ID: 9485094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sarcoma arising in Paget's disease of bone: declining incidence and increasing age at presentation.
    Mangham DC; Davie MW; Grimer RJ
    Bone; 2009 Mar; 44(3):431-6. PubMed ID: 19064007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical assessment of Paget's disease of bone.
    Shankar S; Hosking DJ
    J Bone Miner Res; 2006 Dec; 21 Suppl 2():P22-7. PubMed ID: 17229003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concurrent assays of circulating bone Gla-protein and bone alkaline phosphatase: effects of sex, age, and metabolic bone disease.
    Duda RJ; O'Brien JF; Katzmann JA; Peterson JM; Mann KG; Riggs BL
    J Clin Endocrinol Metab; 1988 May; 66(5):951-7. PubMed ID: 3258870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the serum levels of bone alkaline phosphatase with a new immunoradiometric assay in patients with metabolic bone disease.
    Garnero P; Delmas PD
    J Clin Endocrinol Metab; 1993 Oct; 77(4):1046-53. PubMed ID: 8104954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone alkaline phosphatase in rheumatoid arthritis: a longitudinal study.
    Beyeler C; Banks R; Thompson D; Forbes MA; Cooper EH; Bird HA
    J Rheumatol; 1996 Feb; 23(2):241-4. PubMed ID: 8882026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [What is Paget's disease?].
    Renier JC
    Rev Prat; 1989 Apr; 39(13):1104-8. PubMed ID: 2660231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteocalcin and bone remodelling in Paget's disease of bone, primary hyperparathyroidism, hypercalcaemia of malignancy and involutional osteoporosis.
    Torres R; de la Piedra C; Rapado A
    Scand J Clin Lab Invest; 1989 May; 49(3):279-85. PubMed ID: 2787049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical significance of serum alkaline phosphatase isoenzymes in locomotor diseases.
    Stĕpán J; Susta A; Stĕpán J
    Z Rheumatol; 1975; 34(7-8):261-9. PubMed ID: 1058609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased circulating Dickkopf-1 in Paget's disease of bone.
    Marshall MJ; Evans SF; Sharp CA; Powell DE; McCarthy HS; Davie MW
    Clin Biochem; 2009 Jul; 42(10-11):965-9. PubMed ID: 19389391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is the prevalence of Paget's disease of bone decreasing?
    Cundy T
    J Bone Miner Res; 2006 Dec; 21 Suppl 2():P9-13. PubMed ID: 17229016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.